Coverage of PMC's work in genomics, AI and precision medicine.
We are living in a transformative era for life sciences. Advances in next-generation sequencing have enabled clinicians to detect genetic variants at a greater scale. Yet despite this progress, in my experience, the ability to interpret these variants and translate them into actionable clinical insights remains one of the most significant bottlenecks in precision medicine. Understanding the…
Read more
While quantum computing has a long way to go, it can open tantalizing new doors for the field of genomics. herstockart/iStock via Getty Images Plus Decades after researches first sequenced the human genome, scientists throughout the world are still working to understand it. Despite diligent global efforts to link uncommon variations in DNA sequences with human disease,…
Read more
April 17, 2026 — Personalized Medicine Care (PMC) continues to accelerate the adoption of precision medicine with the American Medical Association (AMA) granting Proprietary Laboratory Analyses (PLA) code approval for four newly developed diagnostic tests. This milestone builds on PMC’s growing portfolio of clinically actionable genomic tools designed to improve diagnostic accuracy, guide treatment decisions, and expand access to personalized…
Read more
Sherry Dadgar, Ph.D., FACMG, trained as a clinical geneticist, completed a fellowship at the National Human Genome Research Institute, and joined the faculty at George Washington University before founding her own company. The decision to start PMCDx in 2020 came from a frustration she had watched build for years inside academic medicine and clinical labs:…
Read more
Rockville, MD (March 16, 2026) — The Maryland Tech Council (MTC), the state’s largest technology and life sciences trade association, has announced the finalists for the 2026 ICON Awards. These prestigious awards recognize outstanding leadership, innovation, and impact across Maryland. Winners will be revealed at the annual Industry Awards Celebration on May 21, 2026, at…
Read more
This milestone represents more than a name change. It reflects our evolution beyond diagnostics and our commitment to advancing precision medicine solutions powered by science, innovation, and emerging technologies to expand access and shape the future of healthcare. We are deeply grateful for the extraordinary support surrounding PMC®. We sincerely thank our distinguished guests for…
Read more
At present, only a few companies such as Natera provide comprehensive genetic testing for kidney disease. With this latest approval, PMC™ stands out as the only laboratory to offer an AMA-recognized panel specifically designed for kidney disease, setting a new benchmark for clinical credibility, diagnostic accuracy, and innovation in the field of nephrogenomics. PMC™ also…
Read more
In the rolling biotech corridor of suburban Maryland, a quiet revolution in personalized medicine is underway. Personalized Medicine Care Diagnostics (PMCDx), a Germantown-based startup founded in 2020, is redefining how advanced diagnostics reach patients, physicians, and health systems. In 2025, Personalized Medicine Care Diagnostics (PMCDx) was proudly recognized by the Montgomery County Executive for its leadership…
Read more
Last month, the Maryland Office of State Procurement had the opportunity to visit Precision Medicine Care (PMC™), an impressive clinical genomics laboratory based in the Germantown Innovation Center in Montgomery County. Led by Sherry Dadgar, Ph.D, FACMG, NYCQ, this dynamic team is on the front lines of advancing precision medicine in Maryland and beyond. PMCDx…
Read more
“We are in the AOL days of AI… That’s how early we are in this transformational phase… The things that are happening in biosciences and things that are to come, there’s so much opportunity to take advantage of right now.”– Jason Michael Perry, PerryLabs This insight set the tone for the fifth edition of Community Connect: Code…
Read more
We are thrilled to share an illuminating discussion with our CEO, Sherry Dadgar, Ph.D, FACMG, NYCQ, and County Executive Marc Elrich, diving into the transformative world of Precision Medicine.
Read more
“The status quo of pharmacotherapy, which is mainly based on trial and error, should change. The doses of many commonly used medications such as Codeine, Plavix and Tamoxifen, and psychiatric medications can be adjusted based on genetic information to increase efficacy and decrease side effects,” says Sherry Dadgar, Ph. D., founder, and CEO of PMCDx.…
Read more
The generous donation will support research into the use of precision medicine in treating renal disease at the GW MFA’s Kidney Precision Medicine Clinic. Through the gift, the clinic will launch pilot studies to test the utility of pharmacogenomics in transplant medicine to tailor immunosuppression. “Dr. Velasquez dedicated his life to helping those in need and…
Read more
Sherry Dadgar ’08 MS (bioinformatics) launched PMCDx in 2020 with a goal of delivering advanced clinical genomic diagnostic testing to patients and their physicians. In less than a year, PMCDx became profitable and has more than 20 employees. A clinical geneticist by training, Dadgar saw issues with the dollar-driven way the health care industry develops…
Read more